Dow Up0.08% Nasdaq Down0.30%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
14.05 Down 0.04(0.28%) Sep 19, 4:00PM EDT
|After Hours : 14.05 0.00 (0.00%) Sep 19, 4:40PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 4,111   11,202   9,265  
Cost of Revenue -   -   -  
Gross Profit 4,111   11,202   9,265  
Operating Expenses
Research Development67,401  47,398  32,439  
Selling General and Administrative14,805  10,016  9,193  
Non Recurring2,334  10,775  9,119  
Others1,013  1,090  1,913  
Total Operating Expenses85,553  69,279  52,664  
Operating Income or Loss (81,442) (58,077) (43,399)
Income from Continuing Operations
Total Other Income/Expenses Net819  530  396  
Earnings Before Interest And Taxes(80,623)(57,547)(43,003)
Interest Expense927  1,576  1,796  
Income Before Tax(81,550)(59,123)(44,799)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(81,550)(59,123)(44,799)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (81,550) (59,123) (44,799)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (81,550) (59,123) (44,799)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.